Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peng Liu, Jianzhou Chen, Liwei Zhao, Antoine Hollebecque, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2022) PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (50)
Hui Pan, Peng Liu, Liwei Zhao, Yuhong Pan, Misha Mao, Guido Kroemer & Oliver Kepp. (2024) Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell & Developmental Biology 156, pages 11-21.
Crossref
Crossref
Christine Moussion & Lélia Delamarre. (2024) Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy. Seminars in Immunology 71, pages 101848.
Crossref
Crossref
Wei Long, Shangfei Li, Yuhan Yang, An Chen, Menghan Xu, Hao Zhai, Ting Cai & Yayun Peng. (2023) Self-Cross-Linked Chitosan/Albumin-Bound Nanoparticle Hydrogel for Inhibition of Postsurgery Malignant Glioma Recurrence. ACS Applied Materials & Interfaces.
Crossref
Crossref
Shasha He, Jie Yu, Mengke Xu, Chi Zhang, Cheng Xu, Penghui Cheng & Kanyi Pu. (2023) A Semiconducting Iron‐Chelating Nano‐immunomodulator for Specific and Sensitized Sono‐metallo‐immunotherapy of Cancer. Angewandte Chemie International Edition 62:43.
Crossref
Crossref
Shasha He, Jie Yu, Mengke Xu, Chi Zhang, Cheng Xu, Penghui Cheng & Kanyi Pu. (2023) A Semiconducting Iron‐Chelating Nano‐immunomodulator for Specific and Sensitized Sono‐metallo‐immunotherapy of Cancer. Angewandte Chemie 135:43.
Crossref
Crossref
Amrita Sarkar, Vojtech Novohradsky, Moumita Maji, Tomer Babu, Lenka Markova, Hana Kostrhunova, Jana Kasparkova, Valentina Gandin, Viktor Brabec & Dan Gibson. (2023) Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death. Angewandte Chemie International Edition 62:42.
Crossref
Crossref
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, Sevda Jafari & Soheila Montazersaheb. (2023) Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds. Cancer Cell International 23:1.
Crossref
Crossref
Sihui Yu, Hongyang Xiao, Li Ma, Jiawen Zhang & Jiarong Zhang. (2023) Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:5, pages 188946.
Crossref
Crossref
Amrita Sarkar, Vojtech Novohradsky, Moumita Maji, Tomer Babu, Lenka Markova, Hana Kostrhunova, Jana Kasparkova, Valentina Gandin, Viktor Brabec & Dan Gibson. (2023) Multitargeting prodrugs that release oxaliplatin, doxorubicin and gemcitabine are potent inhibitors of tumor growth and effective inducers of immunogenic cell death. Angewandte Chemie.
Crossref
Crossref
Shuqin Ji, Man Xu, Chenyu Cai & Xinyue He. (2023) MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil. Biochemical and Biophysical Research Communications 670, pages 1-11.
Crossref
Crossref
Maria Davern, Noel E. Donlon, Andrew S. Sheppard, Klaudia D. Majcher, Fiona O’ Connell, Aisling B. Heeran, Malika Grant, Robert A. Farrell, Conall Hayes, Dara Bracken-Clarke, Melissa J. Conroy, Emma Foley, Dermot O’ Toole, Anshul Bhardwaj, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Jacintha O’ Sullivan & Joanne Lysaght. (2022) FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. Journal of Cancer Research and Clinical Oncology 149:7, pages 3753-3774.
Crossref
Crossref
Jiaqi Zhai, Xi Gu, Yang Liu, Yueting Hu, Yi Jiang & Zhenyong Zhang. (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Frontiers in Pharmacology 14.
Crossref
Crossref
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska-Kołat, Mateusz Gawrysiak, Rafał Drozda, Ismail Celik & Renata Kontek. (2023) PD-1/PD-L1 and DNA Damage Response in Cancer. Cells 12:4, pages 530.
Crossref
Crossref
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng & Ying-Tang Gao. (2023) Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 15:1, pages 1-18.
Crossref
Crossref
Mohammad Darvishi, Foad Tosan, Pooria Nakhaei, Danial Amiri Manjili, Sahar Afzali Kharkouei, Ali Alizadeh, Saba Ilkhani, Farima Khalafi, Firoozeh Abolhasani Zadeh & Seyyed-Ghavam Shafagh. (2023) Recent progress in cancer immunotherapy: Overview of current status and challenges. Pathology - Research and Practice 241, pages 154241.
Crossref
Crossref
Xingyu Chang, Mianli Bian, Lijuan Liu, Jiaqi Yang, Zhibin Yang, Zhaoran Wang, Yunlong Lu & Wukun Liu. (2023) Induction of immunogenic cell death by novel platinum-based anticancer agents. Pharmacological Research 187, pages 106556.
Crossref
Crossref
Hui Pan, Peng Liu, Guido Kroemer & Oliver Kepp. 2023.
Kellsye P. Fabian, Joshua T. Kowalczyk, Sandy T. Reynolds & James W. Hodge. (2022) Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. Cells 11:23, pages 3826.
Crossref
Crossref
Deqian Xie, Qifei Wang & Guangzhen Wu. (2022) Research progress in inducing immunogenic cell death of tumor cells. Frontiers in Immunology 13.
Crossref
Crossref
Reem Ali, Mustapha Aouida, Abdallah Alhaj Sulaiman, Srinivasan Madhusudan & Dindial Ramotar. (2022) Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. International Journal of Molecular Sciences 23:13, pages 7241.
Crossref
Crossref
Maria Davern, Noel E. Donlon, Fiona O’ Connell, Andrew D. Sheppard, Conall Hayes, Ross King, Hugo Temperley, Christine Butler, Anshul Bhardwaj, Jenny Moore, Dara Bracken-Clarke, Claire Donohoe, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Melissa J. Conroy & Joanne Lysaght. (2022) Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma. Translational Oncology 20, pages 101406.
Crossref
Crossref
Fanfei Meng, Jianping Wang, Yanying He, Gregory M. Cresswell, Nadia A. Lanman, L. Tiffany Lyle, Timothy L. Ratliff & Yoon Yeo. (2022) A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity. Proceedings of the National Academy of Sciences 119:22.
Crossref
Crossref
Jeremy Chung Bo Chiang, Ria Arnold, Roshan Dhanapalaratnam, Maria Markoulli & Arun V. Krishnan. (2022) Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders. Pharmaceuticals 15:5, pages 607.
Crossref
Crossref
Aristeidis E. Boukouris, Maria Theochari, Dimitra Stefanou, Alexandros Papalambros, Evangelos Felekouras, Helen Gogas & Dimitrios C. Ziogas. (2022) Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update. Critical Reviews in Oncology/Hematology 173, pages 103663.
Crossref
Crossref
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Thangavelu, Siavash Kamrava, Navid Shomali, Armin D. Sohrabi, Ali Adili, Ali Noroozi-Aghideh & Ehsan Razeghian. (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Communication and Signaling 20:1.
Crossref
Crossref
Maria Davern, Rebecca M. O’ Brien, Jason McGrath, Noel E. Donlon, Ashanty M. Melo, Croí E. Buckley, Andrew D. Sheppard, John V. Reynolds, Niamh Lynam-Lennon, Stephen G. Maher & Joanne Lysaght. (2022) PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma. Scientific Reports 12:1.
Crossref
Crossref
Vinu Krishnan, Vimisha Dharamdasani, Shirin Bakre, Ved Dhole, Debra Wu, Bogdan Budnik & Samir Mitragotri. (2022) Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma. Pharmaceutics 14:2, pages 466.
Crossref
Crossref
Sajal Sen, Miae Won, Matthew S. Levine, Yuvin Noh, Adam C. Sedgwick, Jong Seung Kim, Jonathan L. Sessler & Jonathan F. Arambula. (2022) Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chemical Society Reviews 51:4, pages 1212-1233.
Crossref
Crossref
Somayeh Vafaei, Angelina O. Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi & Majid Zamani. (2022) Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier. Cancer Cell International 22:1.
Crossref
Crossref
Menglu Zhu, Yi Shi, Yifan Shan, Junyan Guo, Xuelong Song, Yuhua Wu, Miaolian Wu, Yan Lu, Wei Chen, Xiaoling Xu & Longguang Tang. (2021) Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Yongxi Zhang, Huijie Jia, Zhiang Liu, Jing Guo, Yang Li, Ruipeng Li, Gaozan Zhu, Jie Li, Minjie Li, Xinyi Li, Shenggen Wang, Chengxue Dang & Tiesuo Zhao. (2021) D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer. International Immunopharmacology 101, pages 108203.
Crossref
Crossref
Jeremy Chung Bo Chiang, David Goldstein, Azadeh Tavakoli, Terry Trinh, Jacob Klisser, Craig R. Lewis, Michael Friedlander, Thomas J. Naduvilath, Kimberley Au, Susanna B. Park, Arun V. Krishnan & Maria Markoulli. (2021) Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel. Scientific Reports 11:1.
Crossref
Crossref
Fei Li, Xue Zheng, Xue Wang, Jinhua Xu & Qianyun Zhang. (2021) Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis. Translational Oncology 14:11, pages 101202.
Crossref
Crossref
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu, Xin Zhang, Xiao-Dong Wang, Guang Cao, Hui Chen, Peng Liu, Hai-Feng Xu, Qin-Zong Gao & Ren-Jie Yang. (2021) Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma. Immunotherapy.
Crossref
Crossref
Jiaxin Wang, Mengxue Zhou, Fangmin Chen, Xiao Liu, Jin Gao, Weiqi Wang, Hui Wang & Haijun Yu. (2021) Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer. Journal of Biomedical Nanotechnology 17:8, pages 1486-1509.
Crossref
Crossref
Seong A Kim, Gi‐hoon Nam, Young Rang Bae, Saurav Kumar Jha, Seohyun Kim, Yoonjeong Choi, Yeji Lee, Minsu Kwon, Cheolhyun Jeong, Youngro Byun, Jin Woo Park & In‐San Kim. (2021) Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity. Advanced Therapeutics 4:8.
Crossref
Crossref
Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers 13:11, pages 2821.
Crossref
Crossref
Maria Davern, Noel E. Donlon, Andrew Sheppard, Fiona O’ Connell, Conall Hayes, Anshul Bhardwaj, Emma Foley, Dermot O’ Toole, Niamh Lynam-Lennon, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher & Joanne Lysaght. (2021) Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells. Translational Oncology 14:6, pages 101062.
Crossref
Crossref
Jan Škubník, Vladimíra Pavlíčková & Silvie Rimpelová. (2021) Cardiac Glycosides as Immune System Modulators. Biomolecules 11:5, pages 659.
Crossref
Crossref
Erwan Eriau, Juliette Paillet, Guido Kroemer & Jonathan G. Pol. (2021) Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy. Cancers 13:6, pages 1260.
Crossref
Crossref
Xiaofei Miao, Ye Zhang, Zengyao Li, Longchang Huang, Taojian Xin, Renhui Shen & Tong Wang. (2021) Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy. Molecular Therapy - Methods & Clinical Development 20, pages 442-450.
Crossref
Crossref
Ying Sun, Yunlong Lu, Mianli Bian, Zhibin Yang, Xiaoyan Ma & Wukun Liu. (2021) Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment. European Journal of Medicinal Chemistry 211, pages 113098.
Crossref
Crossref
Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, Oliver W. L. Carter, Jane M. Donnelly, Cinzia Imberti, Edward C. Lant, Frederik Lermyte, Russell J. Needham, Marta Palau, Peter J. Sadler, Huayun Shi, Fang-Xin Wang, Wen-Ying Zhang & Zijin Zhang. (2020) Metallodrugs are unique: opportunities and challenges of discovery and development. Chemical Science 11:48, pages 12888-12917.
Crossref
Crossref
Maria Davern & Joanne Lysaght. (2020) Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers. Cancer Letters 495, pages 89-99.
Crossref
Crossref
Irina Larionova, Gulnara Tuguzbaeva, Anastasia Ponomaryova, Marina Stakheyeva, Nadezhda Cherdyntseva, Valentin Pavlov, Evgeniy Choinzonov & Julia Kzhyshkowska. (2020) Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers. Frontiers in Oncology 10.
Crossref
Crossref
Erta Kalanxhi, Sebastian Meltzer & Anne Hansen Ree. (2020) Immune-Modulating Effects of Conventional Therapies in Colorectal Cancer. Cancers 12:8, pages 2193.
Crossref
Crossref
Tianxu Fang, Jun Zhang, Tiantian Zuo, Guangyu Wu, Yingxin Xu, Yifan Yang, Jie Yang & Qi Shen. (2020) Chemo-Photothermal Combination Cancer Therapy with ROS Scavenging, Extracellular Matrix Depletion, and Tumor Immune Activation by Telmisartan and Diselenide-Paclitaxel Prodrug Loaded Nanoparticles. ACS Applied Materials & Interfaces 12:28, pages 31292-31308.
Crossref
Crossref
Shuang Yue, Miao Luo, Huiguo Liu & Shuang Wei. (2020) Recent Advances of Gold Compounds in Anticancer Immunity. Frontiers in Chemistry 8.
Crossref
Crossref
Christian Bailly, Xavier Thuru & Bruno Quesnel. (2020) Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times. NAR Cancer 2:1.
Crossref
Crossref
Cédric Rébé, Lucie Demontoux, Thomas Pilot & François Ghiringhelli. (2019) Platinum Derivatives Effects on Anticancer Immune Response. Biomolecules 10:1, pages 13.
Crossref
Crossref